题名

Effects of the extract from roasted chicory (Cichorium intybus L.) root containing inulin-type fructans on blood glucose, lipid metabolism, and fecal properties

DOI

10.1016/j.jtcme.2014.11.016

作者

Mie Nishimura;Tatsuya Ohkawara;Toshiyuki Kanayama;Kazuya Kitagawa;Hiroyuki Nishimura;Jun Nishihira

关键词

fecal property ; glucose metabolism ; lipid metabolism ; roasted chicory root extract ; Hemoglobin A1c

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

5卷3期(2015 / 07 / 01)

页次

161 - 167

内容语文

英文

中文摘要

The extract from roasted chicory (Cichorium intybus L.; 菊苣jú jù) root (chicory root extract), which contains inulin-type fructans, has favorable effects including antihyperglycemic and antidyslipidemic effects and the improvement of bowel movement. In this study, we examined the effects of chicory root extract on blood glucose, lipid metabolism, and fecal properties in 47 healthy adult participants in a randomized, double-blind, placebo-controlled study. The participants were divided into a test group that drank chicory root extract and a placebo group that drank nonchicory root extract (ingesting 300 mL daily for 4 weeks). We performed hematological examinations and body composition measurements, and administered a visual analog scale (VAS) questionnaire for fecal properties at the baseline (Week 0) and after the intervention (Week 4) for the two groups. Although no significant differences in fasting plasma glucose or insulin were observed, hemoglobin A1c was found to decrease by ingesting chicory root extract. No intergroup differences in the levels of lipid metabolism parameters were observed. However, the level of adiponectin was significantly improved in the chicory root extract group when the baseline and postintervention values were compared. In addition, chicory root extract tends to improve the VAS score for fecal properties. These results suggest that chicory root extract could delay or prevent the early onset of diabetes mellitus and improve bowel movements.

主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Alberti, KG,Eckel, RH,Grundy, SM,Zimmet, PZ,Cleeman, JI,Donato, KA(2009).Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.Circulation,120,1640-1645.
  2. Alberti, KG,Zimmet, P,Shaw, J(2006).Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation.Diabet Med,23,469-480.
  3. Asakura, R,Kametani, N,Mitsuda, H,Fukuhara, I,Takahashi, N,Takehara, I(2010).Effect of carbonated beverage containing resistant maltodextrin on the postprandial elevation of blood glucose level - a randomized double-blind crossover study.Jpn Pharmacol Ther,38,621-626.
  4. Franck, A(2002).Technological functionality of inulin and oligofructose.Br J Nutr,87,S287-S291.
  5. García-Peris, P,Velasco, C,Lozano, MA,Moreno, Y,Paron, L,de la Cuerda, C(2012).Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial.Nutr Hosp,27,1908-1915.
  6. Hoshino-Takao, I,Fujii, S,Ishii, A,Han, LK,Okuda, H,Kumao, T(2008).Effects of man-nooligosaccharides from coffee mannan on blood pressure in Dahl salt-sensitive rats.J Nutr Sci Vitaminol,54,181-184.
  7. Keane, D,Kelly, S,Healy, NP,McArdle, MA,Holohan, K,Roche, HM(2013).Diet and metabolic syndrome: an overview.Curr Vasc Pharmacol,11,842-857.
  8. Kubota, K,Sumi, S,Tojo, H,Sumi-Inoue, Y,I-Chin, H,Oi, Y(2011).Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract.Nutr Res,31,421-428.
  9. Letexier, D,Diraison, F,Beylot, M(2003).Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans.Am J Clin Nutr.,77,559-564.
  10. Liber, A,Szajewska, H(2013).Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials.Ann Nutr Metab,63,42-54.
  11. Matsuzawa, Y(2010).Establishment of a concept of visceral fat syndrome and discovery of adiponectin.Proc Jpn Acad Ser B Phys Biol Sci,86,131-141.
  12. Monnier, L,Lapinski, H,Colette, C(2003).Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c.Diabetes Care,26,881-885.
  13. Pereira, AC,Floriano, MS,Mota, GF,Cunha, RS,Herkenhoff, FL,Mill, JG(2003).Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population.Hypertension,42,685-692.
  14. Pourghassem Gargari, B,Dehghan, P,Aliasgharzadeh, A,Asghari Jafar-Abadi, M(2013).Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes.Diabetes Metab J,37,140-148.
  15. Roberfroid, MB(2007).Inulin-type fructans: functional food ingredients.J Nutr.,137,2493S-2502S.
  16. Rosak, C,Mertes, G(2009).Effects of acarbose on proinsulin and insulin secretion and their potential significance for the intermediary metabolism and cardiovas-cular system.Curr Diabetes Rev,5,157-164.
  17. Sales, NM,Pelegrini, PB,Goersch, MC(2014).Nutrigenomics: definitions and advances of this new science.J Nutr Metab,2014,202759.
  18. van Loo, J,Coussement, P,de Leenheer, L,Hoebregs, H,Smits, G(1995).On the presence of inulin and oligofructose as natural ingredients in the Western diet.Crit Rev Food Sci Nutr,35,525-552.
  19. Yamauchi, T,Kamon, J,Minokoshi, Y,Ito, Y,Waki, H,Uchida, S(2002).Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.Nat Med.,8,1288-1295.
  20. Ziegler, MG,Elayan, H,Milic, M,Sun, P,Gharaibeh, M(2012).Epinephrine and the metabolic syndrome.Curr Hypertens Rep,14,1-7.